302 related articles for article (PubMed ID: 23418294)
21. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
[TBL] [Abstract][Full Text] [Related]
22. Incremental Value of Transthoracic Doppler Echocardiography-Assessed Coronary Flow Reserve in Patients With Suspected Myocardial Ischemia Undergoing Myocardial Perfusion Scintigraphy.
Gan LM; Svedlund S; Wittfeldt A; Eklund C; Gao S; Matejka G; Jeppsson A; Albertsson P; Omerovic E; Lerman A
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28420647
[TBL] [Abstract][Full Text] [Related]
23. Physiological basis for angina and ST-segment change PET-verified thresholds of quantitative stress myocardial perfusion and coronary flow reserve.
Johnson NP; Gould KL
JACC Cardiovasc Imaging; 2011 Sep; 4(9):990-8. PubMed ID: 21920337
[TBL] [Abstract][Full Text] [Related]
24. Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy.
Bravo PE; Pozios I; Pinheiro A; Merrill J; Tsui BM; Wahl RL; Bengel FM; Abraham MR; Abraham TP
Am J Cardiol; 2012 Oct; 110(7):1033-9. PubMed ID: 22748357
[TBL] [Abstract][Full Text] [Related]
25. Combined Assessment of Stress Myocardial Perfusion Cardiovascular Magnetic Resonance and Flow Measurement in the Coronary Sinus Improves Prediction of Functionally Significant Coronary Stenosis Determined by Fractional Flow Reserve in Multivessel Disease.
Nakamori S; Sakuma H; Dohi K; Ishida M; Tanigawa T; Yamada A; Takase S; Nakajima H; Sawai T; Masuda J; Nagata M; Ichikawa Y; Kitagawa K; Fujii E; Yamada N; Ito M
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29432130
[TBL] [Abstract][Full Text] [Related]
26. Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements.
Wong DT; Leung MC; Richardson JD; Puri R; Bertaso AG; Williams K; Meredith IT; Teo KS; Worthley MI; Worthley SG
Int J Cardiovasc Imaging; 2012 Dec; 28(8):1971-81. PubMed ID: 22310980
[TBL] [Abstract][Full Text] [Related]
27. Invasive assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: the index of microvascular resistance.
Gutiérrez-Barrios A; Camacho-Jurado F; Díaz-Retamino E; Gamaza-Chulián S; Agarrado-Luna A; Oneto-Otero J; Del Rio-Lechuga A; Benezet-Mazuecos J
Cardiovasc Revasc Med; 2015; 16(7):426-8. PubMed ID: 26235975
[TBL] [Abstract][Full Text] [Related]
28. Higher incidence of vasodilator-induced left ventricular cavity dilation by PET when compared to treadmill exercise-ECHO in hypertrophic cardiomyopathy.
Lu DY; Yalçin H; Sivalokanathan S; Greenland GV; Vasquez N; Yalçin F; Zhao M; Valenta I; Ganz P; Pampaloni MH; Zimmerman S; Schindler TH; Abraham TP; Abraham MR
J Nucl Cardiol; 2020 Dec; 27(6):2031-2043. PubMed ID: 30456498
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance myocardial perfusion imaging at 3.0 Tesla for the identification of myocardial ischaemia: comparison with coronary catheter angiography and fractional flow reserve measurements.
Ebersberger U; Makowski MR; Schoepf UJ; Platz U; Schmidtler F; Rose J; Kessel A; Roth P; Antoni D; Schnackenburg B; Helmberger T; Rieber J; Hoffmann E; Leber AW
Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1174-80. PubMed ID: 23907345
[TBL] [Abstract][Full Text] [Related]
30. Patients with syndrome X have normal transmural myocardial perfusion and oxygenation: a 3-T cardiovascular magnetic resonance imaging study.
Karamitsos TD; Arnold JR; Pegg TJ; Francis JM; Birks J; Jerosch-Herold M; Neubauer S; Selvanayagam JB
Circ Cardiovasc Imaging; 2012 Mar; 5(2):194-200. PubMed ID: 22322441
[TBL] [Abstract][Full Text] [Related]
31. Regional myocardial ischemia in hypertrophic cardiomyopathy: impact of myectomy.
Jörg-Ciopor M; Namdar M; Turina J; Jenni R; Schwitter J; Turina M; Hess OM; Kaufmann PA
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):163-9. PubMed ID: 15282451
[TBL] [Abstract][Full Text] [Related]
32. Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR.
Gyllenhammar T; Fernlund E; Jablonowski R; Jögi J; Engblom H; Liuba P; Arheden H; Carlsson M
Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1350-7. PubMed ID: 25139907
[TBL] [Abstract][Full Text] [Related]
33. Myocardial perfusion abnormality in the area of ventricular septum-free wall junction and cardiovascular events in nonobstructive hypertrophic cardiomyopathy.
Kaimoto S; Kawasaki T; Kuribayashi T; Yamano M; Miki S; Kamitani T; Matsubara H
Int J Cardiovasc Imaging; 2012 Oct; 28(7):1829-39. PubMed ID: 22187199
[TBL] [Abstract][Full Text] [Related]
34. Comparison between quantitative cardiac magnetic resonance perfusion imaging and [
Everaars H; van Diemen PA; Bom MJ; Schumacher SP; de Winter RW; van de Ven PM; Raijmakers PG; Lammertsma AA; Hofman MBM; van der Geest RJ; Götte MJ; van Rossum AC; Nijveldt R; Danad I; Driessen RS; Knaapen P
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(7):1688-1697. PubMed ID: 31822958
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular magnetic resonance detects microvascular dysfunction in a mouse model of hypertrophic cardiomyopathy.
Ku MC; Kober F; Lai YC; Pohlmann A; Qadri F; Bader M; Carrier L; Niendorf T
J Cardiovasc Magn Reson; 2021 May; 23(1):63. PubMed ID: 34053450
[TBL] [Abstract][Full Text] [Related]
36. "Myocardial transit-time" (MyoTT): a novel and easy-to-perform CMR parameter to assess microvascular disease.
Chatzantonis G; Bietenbeck M; Florian A; Meier C; Korthals D; Reinecke H; Yilmaz A
Clin Res Cardiol; 2020 Apr; 109(4):488-497. PubMed ID: 31321491
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Fractional Flow Reserve in Patients With Recent Non-ST-Segment-Elevation Myocardial Infarction: Comparative Study With 3-T Stress Perfusion Cardiac Magnetic Resonance Imaging.
Layland J; Rauhalammi S; Watkins S; Ahmed N; McClure J; Lee MM; Carrick D; O'Donnell A; Sood A; Petrie MC; May VT; Eteiba H; Lindsay M; McEntegart M; Oldroyd KG; Radjenovic A; Berry C
Circ Cardiovasc Interv; 2015 Aug; 8(8):e002207. PubMed ID: 26253733
[TBL] [Abstract][Full Text] [Related]
38. Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography.
Timmer SA; Knaapen P
Eur Heart J Cardiovasc Imaging; 2013 Feb; 14(2):95-101. PubMed ID: 23152441
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular magnetic resonance profiling of coronary atherosclerosis: vessel wall remodelling and related myocardial blood flow alterations.
Jahnke C; Manka R; Kozerke S; Schnackenburg B; Gebker R; Marx N; Paetsch I
Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1400-10. PubMed ID: 25104810
[TBL] [Abstract][Full Text] [Related]
40. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease.
Murthy VL; Naya M; Foster CR; Hainer J; Gaber M; Dorbala S; Charytan DM; Blankstein R; Di Carli MF
JACC Cardiovasc Imaging; 2012 Oct; 5(10):1025-34. PubMed ID: 23058070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
